Literature DB >> 10382703

Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids.

A M Wilson, O J Dempsey, W J Coutie, E J Sims, B J Lipworth.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10382703     DOI： 10.1016/S0140-6736(99)01443-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

2.  Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers.

Authors:  Arun Nair; Lorna McKinlay; Peter Williamson; Philip Short; Patricia Burns; Brian J Lipworth
Journal:  Eur J Clin Pharmacol       Date:  2011-01-15       Impact factor: 2.953

Review 3.  Safety of inhaled corticosteroids in the treatment of persistent asthma.

Authors:  Stephen P Peters
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

4.  Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom.

Authors:  G R G Todd; C L Acerini; R Ross-Russell; S Zahra; J T Warner; D McCance
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

Review 5.  Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.

Authors:  B J Lipworth; C M Jackson
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

6.  Prescribing for osteoporosis following the use of inhaled and oral glucocorticoids in general practice.

Authors:  David Williams; Kathleen Bennett; John Feely
Journal:  Br J Clin Pharmacol       Date:  2004-12       Impact factor: 4.335

7.  Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler.

Authors:  Arun Nair; Daniel Menzies; Martyn Barnes; Patricia Burns; Lesley McFarlane; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

8.  In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.

Authors:  Arun Nair; Daniel Menzies; Pippa Hopkinson; Lesley McFarlane; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2009-02-09       Impact factor: 4.335

Review 9.  Pharmacological factors that influence the choice of inhaled corticosteroids.

Authors:  S Edsbäcker
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 10.  Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations.

Authors:  Tanya Gulliver; Ronald Morton; Nemr Eid
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.